These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1198 related items for PubMed ID: 27291511

  • 1. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD).
    Guerra F, Palmisano P, Dell'Era G, Ziacchi M, Ammendola E, Bonelli P, Patani F, Cupido C, Devecchi C, Accogli M, Occhetta E, Santangelo L, Biffi M, Boriani G, Capucci A, Italian Association of Arrhythmology and Cardiac Pacing (AIAC).
    Heart Rhythm; 2016 Oct; 13(10):1987-92. PubMed ID: 27291511
    [Abstract] [Full Text] [Related]

  • 2. Electrical Storm in ICD Recipients with Arrhythmogenic Right Ventricular Cardiomyopathy.
    Yin K, Ding L, Hua W, Zhang S.
    Pacing Clin Electrophysiol; 2017 Jun; 40(6):683-692. PubMed ID: 28261825
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH, Lin YJ, Huang JL, Wu TJ, Cheng CC, Lin WS, Tuan TC, Chang SL, Lo LW, Hu YF, Chao TF, Chung FP, Tsai CF, Tsao HM, Chen SA.
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [Abstract] [Full Text] [Related]

  • 4. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
    Alsheikh-Ali AA, Link MS, Semsarian C, Shen WK, Estes NA, Maron MS, Haas TS, Formisano F, Boriani G, Spirito P, Maron BJ.
    Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
    [Abstract] [Full Text] [Related]

  • 5. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.
    Kleemann T, Strauss M, Kouraki K, Zahn R.
    Europace; 2015 Jul; 17(7):1068-75. PubMed ID: 25687746
    [Abstract] [Full Text] [Related]

  • 6. Cardiac resynchronization therapy and electrical storm: results of the OBSERVational registry on long-term outcome of ICD patients (OBSERVO-ICD).
    Guerra F, Palmisano P, Dell'Era G, Ziacchi M, Ammendola E, Pongetti G, Bonelli P, Patani F, Devecchi C, Accogli M, Occhetta E, Nigro G, Biffi M, Boriani G, Capucci A, Italian Association of Arrhythmology and Cardiac Pacing (AIAC).
    Europace; 2018 Jun 01; 20(6):979-985. PubMed ID: 28595339
    [Abstract] [Full Text] [Related]

  • 7. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM, Kutyifa V, Arshad A, McNitt S, Polonsky B, Wang PJ, Moss AJ, Zareba W.
    J Cardiovasc Electrophysiol; 2015 Aug 01; 26(8):862-871. PubMed ID: 25929699
    [Abstract] [Full Text] [Related]

  • 8. Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial.
    Sullivan RM, Russo AM, Berg KC, Stolen KQ, Seth M, Perschbacher D, Day JD, Olshansky B.
    Heart Rhythm; 2012 Mar 01; 9(3):351-8. PubMed ID: 22016074
    [Abstract] [Full Text] [Related]

  • 9. Electrical storm and heart failure worsening in implantable cardiac defibrillator patients.
    Guerra F, Flori M, Bonelli P, Patani F, Capucci A.
    Europace; 2015 Feb 01; 17(2):247-54. PubMed ID: 25345831
    [Abstract] [Full Text] [Related]

  • 10. Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis.
    Guerra F, Shkoza M, Scappini L, Flori M, Capucci A.
    Europace; 2014 Mar 01; 16(3):347-53. PubMed ID: 24096960
    [Abstract] [Full Text] [Related]

  • 11. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
    Schaer B, Kühne M, Reichlin T, Osswald S, Sticherling C.
    Europace; 2016 Feb 01; 18(2):227-31. PubMed ID: 26063686
    [Abstract] [Full Text] [Related]

  • 12. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, PREPARE Study Investigators.
    J Am Coll Cardiol; 2008 Aug 12; 52(7):541-50. PubMed ID: 18687248
    [Abstract] [Full Text] [Related]

  • 13. Reprogramming the tachycardia parameters with long-detection strategy in patients with pre-existing implantable cardioverter-defibrillator.
    Bozyel S, Aktas M, Mutluer FO, Guler TE, Dervis E, Argan O, Celikyurt U, Agir A, Vural A.
    Acta Cardiol; 2019 Jun 12; 74(3):246-251. PubMed ID: 30058473
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F, Jarman JW, Clague JR, Till J.
    Heart Rhythm; 2014 Jan 12; 11(1):58-66. PubMed ID: 24120999
    [Abstract] [Full Text] [Related]

  • 15. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD.
    J Cardiovasc Electrophysiol; 2012 Mar 12; 23(3):296-301. PubMed ID: 21955243
    [Abstract] [Full Text] [Related]

  • 16. Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III Trial.
    Gasparini M, Lunati MG, Proclemer A, Arenal A, Kloppe A, Martínez Ferrer JB, Hersi AS, Gulaj M, Wijffels MCE, Santi E, Manotta L, Varma N.
    JACC Clin Electrophysiol; 2017 Nov 12; 3(11):1275-1282. PubMed ID: 29759624
    [Abstract] [Full Text] [Related]

  • 17. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators.
    Brigadeau F, Kouakam C, Klug D, Marquié C, Duhamel A, Mizon-Gérard F, Lacroix D, Kacet S.
    Eur Heart J; 2006 Mar 12; 27(6):700-7. PubMed ID: 16421175
    [Abstract] [Full Text] [Related]

  • 18. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial.
    Exner DV, Pinski SL, Wyse DG, Renfroe EG, Follmann D, Gold M, Beckman KJ, Coromilas J, Lancaster S, Hallstrom AP, AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators.
    Circulation; 2001 Apr 24; 103(16):2066-71. PubMed ID: 11319196
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of high-rate cutoff and long detection interval ICD programming in secondary prevention patients.
    Hayashi Y, Takagi M, Kakihara J, Sakamoto S, Doi A, Sugioka K, Hanatani A, Yoshiyama M.
    Heart Vessels; 2017 Feb 24; 32(2):175-185. PubMed ID: 27259484
    [Abstract] [Full Text] [Related]

  • 20. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA, Koneru JN, Sharma PS, Deshpande S, Wan C, Szymkiewicz SJ.
    JACC Clin Electrophysiol; 2017 Mar 24; 3(3):243-250. PubMed ID: 29759518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.